CA
NZ
UK
AU
IND
US
Aggregates gross profit fell 4% to USD 512 million, with the company citing higher depreciation, depletion and amortization and energy-related costs. Total depreciation, depletion and amortization in cost of revenues was USD 231 million against USD 143 million. Acquisition, divestiture and integration expenses were …
Cost of operations rose 19.0% to USD 182.4 million, soGross Profitgrew 17.6% to USD 29.8 million. Selling, general and administrative expenses rose 3.5% to USD 22.0 million but fell to 10.4% of sales from 11.9%. The effective tax rate dropped to 19.2% from 28.4% …
Operating expenses were USD 79.9 million against USD 71.4 million, withResearch and Developmentat USD 68.9 million and general and administrative at USD 11.0 million. The R&D rise includes USD 17.0 million of accrued milestone license fees owed to MHKDG on expected BLA acceptance and …
The company develops lorundrostat, an oral aldosterone synthase inhibitor for uncontrolled or resistant hypertension. It submitted its new drug application in December 2025, the FDA accepted it, and the target action date is December 22, 2026. The filing says an advisory committee meeting is …
The company simultaneously announced that board member Tony Weisman is President and Chief Executive Officer, succeeding Mark Douglas. Weisman is a former Dunkin' U.S. chiefMarketingofficer and former CEO of Digitas. He said theBusinesshas strong product-market fit and needs operational rigor and a culture of …
Gross margin rose to 52.4%. Separately, the filing notes a favorable cost of sales adjustment of approximately USD 70 million over the nine months forTariffrefunds the company now considers probable after a Supreme Court ruling invalidated IEEPA tariffs. Selling, general and administrative expense fell …
Net premiums earned fell to USD 238.5 million, which the company attributes mainly to higher ceded premiums under reinsurance. Net premiumYielddropped to 31.2 basis points from 32.3. Losses incurred, net rose 119% to USD 23.9 million, a 10.0% loss ratio against 4.5%, as new …
Key HighlightsFirst-quarter fiscal 2027Net Incomewas USD 6.2 million, or USD 0.22 per diluted share, against a net loss of USD 3.7 million, or USD 0.13 per share, a year earlier.Adjusted net income, which excludes restructuring expense, was USD 6.4 million, or USD 0.23 per …
The prior-year quarter included a USD 115.0 million impairment tied to the Dalmatian field; there was none this year.Leaseoperating expenses fell to USD 149.2 million from USD 184.4 million on lower workover activity and insurance proceeds. Offsetting items were a USD 35.2 million rise …
For the fiscal year ended September 30, 2026, adjusted EBITDA rose 14.1% to USD 372.2 million, a 25.2% margin versus 22.8%. Net income was USD 221.9 million against USD 191.7 million.Operating Cash Flowrose 19.9% to USD 262.9 million, free cash flow reached USD 207.3 …
Please wait processing your request...